Cargando…
Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review
BACKGROUND: High-dose methotrexate (HD-MTX) is used in the treatment of different childhood cancers, including leukemia, the most common cancer type and is commonly defined as an intravenous dose of at least 1 g/m(2) body surface area per application. A systematic review on late effects on different...
Autores principales: | Daetwyler, Eveline, Bargetzi, Mario, Otth, Maria, Scheinemann, Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919635/ https://www.ncbi.nlm.nih.gov/pubmed/35287628 http://dx.doi.org/10.1186/s12885-021-09145-0 |
Ejemplares similares
-
Feasibility of a registry for standardized assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer
por: Otth, Maria, et al.
Publicado: (2022) -
Young Survivors at KSA: registry for standardised assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer—a study protocol
por: Otth, Maria, et al.
Publicado: (2021) -
Interventions to improve neurocognitive late-effects in pediatric and adolescent CNS tumor patients and survivors - a systematic review
por: Kasteler, Rahel, et al.
Publicado: (2023) -
Back to school – The teachers’ worries and needs having a childhood cancer patient or survivor in their class
por: Otth, Maria, et al.
Publicado: (2022) -
Aftercare of Childhood Cancer Survivors in Switzerland: Protocol for a Prospective Multicenter Observational Study
por: Denzler, Sibylle, et al.
Publicado: (2020)